Gentium S.p.A. Release: Data From Non HSCT VOD Patients Treated With Defibrotide and a Treatment IND Update to be Presented at the American Society of Hematology Annual Meeting

Published: Dec 07, 2012

VILLA GUARDIA (COMO), Italy, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) (the "Company") today announced that an oral presentation and poster abstracts on Defibrotide will be presented at the 54th Annual Meeting and Exposition of the American Society of Hematology to be held at the Georgia World Congress Center in Atlanta, Georgia, December 8-11, 2012.

Back to news